首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Frequency-specific and D-2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling
【24h】

Frequency-specific and D-2 receptor-mediated inhibition of glutamate release by retrograde endocannabinoid signaling

机译:逆行性内源性大麻素信号传导的频率特异性和D-2受体介导的谷氨酸释放抑制

获取原文
获取原文并翻译 | 示例
           

摘要

The mechanisms underlying modulation of corticostriatal synaptic transmission by D-2-like receptors (D(2)Rs) have been controversial. A recent study suggested that D(2)Rs inhibit glutamate release at this synapse, but only during high-frequency synaptic activation. Because the release of postsynaptic endocannabinoids (eCBs), which act as retrograde messengers to inhibit presynaptic glutamate release, can be triggered by D2R activation and intense synaptic activation, such a mechanism could mediate dopaminergic modulation of corticostriatal transmission. Here, we show that D2R activation reduces excitatory transmission onto striatal medium spiny neurons at a stimulation frequency of 20 Hz but not at 1 Hz. This form of inhibition requires CB1 receptor activation, as evidenced by the fact that it is blocked by AM251 [N-(piperidin-1-yl)1-(2,4-dichlorophenyl)-5-(4-chlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide], a CB1 antagonist, and is absent in CB1 knockout mice. It is also blocked by postsynaptic intracellular calcium chelation, by group I metabotropic glutamate receptor antagonism, and by inhibition of postsynaptic phospholipase C. These results demonstrate a previously unrecognized role for retrograde eCB signaling in reversible and frequency-specific inhibition of glutamate release by the activation of striatal D(2)Rs.
机译:D-2样受体(D(2)Rs)调节皮质口突触传递的基础机制一直存在争议。最近的研究表明D(2)Rs抑制谷氨酸释放在此突触,但仅在高频突触激活期间。由于D2R激活和强烈的突触激活可以触发突触后内源性大麻素(eCBs)的释放(其是逆行信使来抑制突触前谷氨酸的释放),因此这种机制可以介导多巴胺能调节皮质类固醇的传递。在这里,我们显示D2R激活以20 Hz的刺激频率而不是1 Hz的刺激减少了向纹状体中棘神经元的兴奋性传递。这种抑制形式需要CB1受体激活,这一事实已被AM251 [N-(piperidin-1-yl)1-(2,4-dichlorophenyl)-5-(4-chlorophenyl)-4-甲基-1H-吡唑-3-羧酰胺],一种CB1拮抗剂,在CB1基因敲除小鼠中不存在。它也受到突触后细胞内钙螯合,I组代谢型谷氨酸受体拮抗作用和突触后磷脂酶C抑制作用的阻滞。这些结果证明了逆行eCB信号在激活中可逆和特定频率抑制谷氨酸释放方面以前未被认识的作用。纹状体D(2)Rs。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号